Inflammatory Mechanisms in Knee Osteoarthritis

Knee osteoarthritis arises from a complex interplay of mechanical stress and chronic low‐grade inflammation within joint tissues. Early synovial activation leads to macrophage infiltration and release of proinflammatory cytokines such as interleukin-1β, tumour necrosis factor-α and interleukin-6. These mediators stimulate production of degradative enzymes, notably matrix metalloproteinases, driving cartilage matrix breakdown. Concurrent subchondral bone remodelling and osteophyte formation alter joint biomechanics and perpetuate inflammation. Emerging data highlight roles for chemokines, adipokines and damage-associated molecular patterns in modulating cartilage catabolism and nociceptive sensitisation. Nuclear factor κB signalling and inducible nitric oxide synthase coordinate transcriptional regulation of inflammatory genes. Metabolic factors, including dyslipidaemia and mitochondrial dysfunction, further fuel synovial inflammation and pain. Unravelling these interdependent pathways underpins targeted therapeutic strategies—from cytokine inhibitors and NF-κB modulators to metabolic interventions—aimed at interrupting the inflammatory cascade and preserving joint function.

Research from Nature Portfolio

Analyses of synovial fluid in patients with ultrasound-confirmed joint effusion have demonstrated that elevated interleukin-8 levels are significantly associated with clinical severity scores, including pain and functional measures. In the same samples, interleukin-8 concentrations correlate with local tumour necrosis factor-α, interleukin-6 and adipokines such as osteopontin and visfatin, whereas no parallel associations are observed in serum. These findings reinforce the notion that local synovial inflammation, rather than systemic markers, is a primary driver of symptom severity in knee osteoarthritis.

Inflammatory Mechanisms in Knee Osteoarthritis publication trend

The graph below shows the total number of articles in inflammatory mechanisms in knee osteoarthritis across all publications each year (not limited to Nature Index journals).

Technical terms

Cytokine: A small protein secreted by immune cells that modulates inflammation and cell signalling.

Chemokine: A subclass of cytokines responsible for directing the migration of immune cells.

Synovium: The membrane lining the joint capsule that produces synovial fluid and can become inflamed (synovitis).

Subchondral bone: The layer of bone just below the cartilage surface, which undergoes remodelling in osteoarthritis.

Osteophyte: A bony outgrowth, commonly known as a bone spur, formed at joint margins in osteoarthritis.

NF-κB: A transcription factor that regulates the expression of inflammatory genes.

iNOS: Inducible nitric oxide synthase, an enzyme that generates nitric oxide to mediate inflammatory responses.

References

1. Serum lipid biomarkers and inflammatory cytokines associated with onset and clinical status of patients with early knee osteoarthritis. Frontiers in Nutrition (2023).
2. Metabolic Dysregulation and Its Role in Postoperative Pain among Knee Osteoarthritis Patients. International Journal of Molecular Sciences (2024).
3. Synovial fluid but not plasma interleukin-8 is associated with clinical severity and inflammatory markers in knee osteoarthritis women with joint effusion. Scientific Reports (2021).
4. Immunofluorescence Analysis of NF-kB and iNOS Expression in Different Cell Populations during Early and Advanced Knee Osteoarthritis. International Journal of Molecular Sciences (2021).